Method of treating skin wounds with vectors encoding...

Details Method of treating skin wounds with vectors encoding... Method of treating skin wounds with vectors encoding...

2007-07-24

2007-07-24

Woitach, Joseph (Department: 1633)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C424S093100, C536S023500

Reexamination Certificate

active

10477166

ABSTRACT:
The present invention relates to a therapeutic preventive agent that includes an angiogenic factor gene (such as hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and hypoxia inducible factor (HIF)) as its active ingredient, and the administration of such an agent into the targeted skin diseases-affected area.

REFERENCES:
patent: 5827703 (1998-10-01), Debs et al.
patent: 0 847 757 (1998-06-01), None
patent: 1210046 (2000-12-01), None
patent: 1221490 (2002-07-01), None
patent: WO 00/78259 (2000-12-01), None
patent: WO 01/21761 (2001-03-01), None
patent: WO 02/44393 (2002-06-01), None
patent: WO 03/103721 (2003-12-01), None
Rinsch, et al. (2001) Gene Therapy, 8: 523-33.
Deonarain (1998) Exp. Opin. Ther. Pat., 8(1): 53-69.
Gorecki (2001) Exp. Opin. Emerging Drugs, 6(2): 187-98.
Verma, et al. (1997) Nature, 389: 239-42.
Eck, et al. (1996) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., McGraw-Hill, New York, NY., pp. 77-101.
Pfeifer and Verma (2001) Annu. Rev. Genomics. Hum. Genet. 2:177-211.
Johnson-Saliba et al. (2001) Curr. Drug. Targets 2:371-99.
Shoji et al. (2004) Current Pharmaceutical Design 10 :785-796.
Cotsarelis, et al. (2001) Trends in Mol. Med., 7(7): 293-301.
Otomo (2002) Nippon Yakurigaku Zasshi, 119(3): 167-74, Abstract Only.
Jindo, et al. (1995) J. Dermatol. Sci., 10: 229-32.
Meagher, et al. (2002) Austral. J. Dermatol., 43: 247-54.
Boguniewcz, et al. (2006) J. Allergy Clin Immunol., 117(2): S475-80.
Nayeri, et al. (2002) J. Dermatol. Treat., 13: 81-86.
Game et al (2001) Wien Klin Wochenschr,113:823-38.
Hamoen, et al. (2002) Cell Transplantation, 11: 385-95.
Cioce, et al. (1996) J. Biol. Chem., 271(22): 13110-15.
Ueda, et al. (1999) Ann. Thorac. Surg., 67: 1726-31.
Rudinger (1976) Peptide Hormones, University Park Press, Baltimore, MD., pp. 1-7.
Bowie, et al. (1990) Science, 247 : 1306-10.
Sawamura, et al. (1997) J Invest Dermatol., 108: 195-99.
Kunugiza et al., “Effective Acceleration of Wound Healing by Simultaneous Transfestion of Hepatocyte Growth Factor Gene and Prostacyclin Synthase Gene Using Shima Jet,”Mol. Ther. 9:S397, #1036 (2004).
Nakanishi et al., “Gene Transfer of Human Hepatocyte Growth Factor into Rat Skin Wounds Mediated by Liposomes Coated with the Sendai Virus (Hemagglutinating Virus of Japan),”Am. J. Pathol. 161:1761-1772 (2002).
Corral et al., “Vascular Endothelial Growth Factor is More Important Than Basic Fibroblastic Growth Factor During Inchemic Wound Healing,”Arch. Surg. 134:200-205 (1999).
Dunsmore et al., “Mechanisms of Hepatocyte Growth Factor Stimulation of Keratinocyte Metalloproteinase Production,”J. Biol. Chem. 271:24576-24582 (1996).
Gille et al., “Transforming Growth Factor-α-Induced Transcriptional Activation of the Vascular Permeability Factor (VPF/VEGF) Gene Requires AP-2-Dependent DNA Binding and Transactivation,”EMBO J. 16:750-759 (1997).
Hamoen et al., “Genetically Modified Keratinocytes in a Human Skin Model: Hepatocyte Growth Factor Promotes Wound Healing,”Surgical Forum 50:582-584 (1999).
Kunisada et al., “Keratinocyte Expression of Transgenic Hepatocyte Growth Factor Affects Melanocyte Development, Leading to Dermal Melanocytosis,”Mech. Dev. 94:67-78 (2000).
Scheid et al., “Hypoxia-Regulated Gene Expression in Fetal Wound Regeneration and Adult Wound Repair,”Pediatr. Surg. Int. 16:232-236 (2000).
Zeigler et al., “Growth Factor-Induced Epidermal Invasion of the Dermis in Human Skin Organ Culture: Expression and Role of Matrix Metalloproteinases,”Invasion Metastasis 16:11-18 (1996).
Andree et al., “In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair,”Proc. Natl. Acad. Sci. USA91:12188-12192 (1994).
Eming et al., “Particle-Mediated Gene Transfer of PDGF Isoforms Promotes Wound Repair,”J. Invest. Dermatol.112:297-302 (1999).
Jeschke et al., “Biodistribution and Feasibility of Non-Viral IGF-I Gene Transfers in Thermally Injured Skin,”Lab. Invest.80(2):151-158 (2000).

Affiliated with

Also associated with

Rating

Method of treating skin wounds with vectors encoding... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating skin wounds with vectors encoding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating skin wounds with vectors encoding... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3725091